\-\ Texto\\:\\ \ \(0\)\
\-\ given\\ the\\ size\\ of\\ this\\ mass\\ and\\ associated\\ patient\\'s\\ symptoms\\,\\ selective\\ embolization\\ was\\ attempted\\,\\ followed\\ by\\ cryo\\-ablation\\.\ \(0\)\
\-\ large\\ right\\ adrenal\\ mass\\ that\\ measures\\ approximately\\ 13\\ x\\ 14\\ x\\ 18\\ cm\\ consisting\\ of\\ predominantly\\ fat\\ attenuation\\ with\\ considerable\\ mass\\ effect\\ on\\ right\\ kidney\\.\ \(0\)\
\-\ adrenal\\ myelolipoma\ \(1\)\
\-\ \\â\\€\\¢\\ myelolipoma\ \(1\)\
\-\ \\â\\€\\¢\\ adrenal\\ adenoma\ \(1\)\
\-\ \\â\\€\\¢\\ retroperitoneal\\ liposarcoma\ \(1\)\
\-\ \\â\\€\\¢\\ pheochromocytoma\ \(2\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ adrenal\\ carcinoma\ \(2\)\
\-\ 62\\ y\\/o\\ man\\ with\\ right\\ flank\\ pain\\.\ \(1\)\
\-\ this\\ patient\\ was\\ found\\ to\\ have\\ an\\ incidental\\ right\\ adrenal\\ mass\\ approximately\\ 30\\ years\\ ago\\ during\\ a\\ laminectomy\\,\\ and\\ the\\ mass\\ was\\ left\\ alone\\ because\\ of\\ its\\ benign\\ gross\\ anatomical\\ appearance\\.\\ \\ the\\ patient\\ began\\ having\\ symptoms\\ to\\ include\\ right\\ flank\\ which\\ instigated\\ further\\ work\\ up\\ to\\ include\\ imaging\\.\ \(0\)\
\-\ this\\ patient\\ was\\ not\\ an\\ appropriate\\ surgical\\ candidate\\ so\\ interventional\\ radiology\\ was\\ consulted\\ for\\ selective\\ embolization\\ of\\ the\\ mass\\.\\ \\ the\\ patient\\'s\\ symptoms\\ persisting\\ after\\ the\\ procedure\\ for\\ several\\ months\\,\\ and\\ so\\ cryo\\-ablation\\ was\\ attempted\\ which\\ has\\ resulted\\ in\\ decrease\\ in\\ symptoms\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adrenal\\:\\ 0\\.4027348806306324\ \(0\)\
\-\ myelolipoma\\:\\ 0\\.2111695881955578\ \(0\)\
\-\ selective\\:\\ 0\\.20646914795957905\ \(0\)\
\-\ mass\\:\\ 0\\.19932169738584185\ \(0\)\
\-\ symptoms\\:\\ 0\\.19034059974629586\ \(0\)\
\-\ was\\:\\ 0\\.18185978980303133\ \(0\)\
\-\ attempted\\:\\ 0\\.17549118573192615\ \(0\)\
\-\ flank\\:\\ 0\\.15256870969595546\ \(0\)\
\-\ embolization\\:\\ 0\\.15159286628723856\ \(0\)\
\-\ so\\:\\ 0\\.14631483488807204\ \(0\)\
\-\ right\\:\\ 0\\.1441710475570043\ \(0\)\
\-\ patient\\:\\ 0\\.1414351499916858\ \(0\)\
\-\ instigated\\:\\ 0\\.13908423380951462\ \(0\)\
\-\ persisting\\:\\ 0\\.11794844056740732\ \(0\)\
\-\ approximately\\:\\ 0\\.11098660283329104\ \(0\)\
\-\ laminectomy\\:\\ 0\\.10836451450641071\ \(0\)\
\-\ the\\:\\ 0\\.1041222003929093\ \(0\)\
\-\ include\\:\\ 0\\.10349291755937604\ \(0\)\
\-\ considerable\\:\\ 0\\.10323457397978952\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.09831348948701674\ \(0\)\
\-\ consisting\\:\\ 0\\.09681264732530001\ \(0\)\
\-\ anatomical\\:\\ 0\\.09681264732530001\ \(0\)\
\-\ candidate\\:\\ 0\\.09501689747672526\ \(0\)\
\-\ consulted\\:\\ 0\\.0941925749937133\ \(0\)\
\-\ liposarcoma\\:\\ 0\\.0930340747038456\ \(0\)\
\-\ interventional\\:\\ 0\\.09266667735873586\ \(0\)\
\-\ this\\:\\ 0\\.08965354889443365\ \(0\)\
\-\ resulted\\:\\ 0\\.0885553186489153\ \(0\)\
\-\ alone\\:\\ 0\\.08554632697171947\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.083826618438121\ \(0\)\
\-\ 62\\:\\ 0\\.08284264787806395\ \(0\)\
\-\ began\\:\\ 0\\.08087842944190138\ \(0\)\
\-\ which\\:\\ 0\\.07909240238046945\ \(0\)\
\-\ gross\\:\\ 0\\.07717769624490942\ \(0\)\
\-\ appropriate\\:\\ 0\\.07640881473952704\ \(0\)\
\-\ predominantly\\:\\ 0\\.07616090273988703\ \(0\)\
\-\ having\\:\\ 0\\.07497843035066584\ \(0\)\
\-\ decrease\\:\\ 0\\.07475255581867547\ \(0\)\
\-\ measures\\:\\ 0\\.07090850169907796\ \(0\)\
\-\ work\\:\\ 0\\.07090850169907796\ \(0\)\
\-\ radiology\\:\\ 0\\.0696546789254236\ \(0\)\
\-\ adenoma\\:\\ 0\\.06933703718531666\ \(0\)\
\-\ procedure\\:\\ 0\\.06933703718531666\ \(0\)\
\-\ of\\:\\ 0\\.06807870855760667\ \(0\)\
\-\ attenuation\\:\\ 0\\.06654422424513934\ \(0\)\
\-\ an\\:\\ 0\\.06651420143622257\ \(0\)\
\-\ 18\\:\\ 0\\.06590353115122899\ \(0\)\
\-\ 13\\:\\ 0\\.06559300611883337\ \(0\)\
\-\ to\\:\\ 0\\.06522711429847268\ \(0\)\
\-\ 14\\:\\ 0\\.06493132921549061\ \(0\)\
\-\ incidental\\:\\ 0\\.06446752913074644\ \(0\)\
\-\ its\\:\\ 0\\.06435375060234438\ \(0\)\
\-\ ago\\:\\ 0\\.06363419319666036\ \(0\)\
\-\ kidney\\:\\ 0\\.06109972609866579\ \(0\)\
\-\ effect\\:\\ 0\\.061008430903429764\ \(0\)\
\-\ because\\:\\ 0\\.06078255637143942\ \(0\)\
\-\ given\\:\\ 0\\.05982663780098486\ \(0\)\
\-\ benign\\:\\ 0\\.05974263619979407\ \(0\)\
\-\ 30\\:\\ 0\\.05932943334741952\ \(0\)\
\-\ size\\:\\ 0\\.058887482054004396\ \(0\)\
\-\ followed\\:\\ 0\\.05872989665058048\ \(0\)\
\-\ several\\:\\ 0\\.057060962766029774\ \(0\)\
\-\ further\\:\\ 0\\.056645130115969035\ \(0\)\
\-\ found\\:\\ 0\\.05627366373989015\ \(0\)\
\-\ during\\:\\ 0\\.05508671059995731\ \(0\)\
\-\ fat\\:\\ 0\\.05410081123326249\ \(0\)\
\-\ and\\:\\ 0\\.05391396200150869\ \(0\)\
\-\ years\\:\\ 0\\.05331154988624394\ \(0\)\
\-\ for\\:\\ 0\\.05271998155596263\ \(0\)\
\-\ appearance\\:\\ 0\\.0524309441427713\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0520216242019287\ \(0\)\
\-\ lymphoma\\:\\ 0\\.051796120882386124\ \(0\)\
\-\ months\\:\\ 0\\.050623674647220236\ \(0\)\
\-\ cm\\:\\ 0\\.04994795466282869\ \(0\)\
\-\ metastatic\\:\\ 0\\.04769878712387971\ \(0\)\
\-\ man\\:\\ 0\\.046043087339437766\ \(0\)\
\-\ associated\\:\\ 0\\.04583980096711449\ \(0\)\
\-\ imaging\\:\\ 0\\.04570576711883649\ \(0\)\
\-\ large\\:\\ 0\\.04357637189212396\ \(0\)\
\-\ have\\:\\ 0\\.0434463699027287\ \(0\)\
\-\ in\\:\\ 0\\.043270711051323726\ \(0\)\
\-\ up\\:\\ 0\\.04302086548474651\ \(0\)\
\-\ surgical\\:\\ 0\\.042270339138297856\ \(0\)\
\-\ after\\:\\ 0\\.04219065471275616\ \(0\)\
\-\ has\\:\\ 0\\.03972543913461445\ \(0\)\
\-\ that\\:\\ 0\\.0377417918611777\ \(0\)\
\-\ by\\:\\ 0\\.03693257783194316\ \(0\)\
\-\ disease\\:\\ 0\\.03650698733797503\ \(0\)\
\-\ not\\:\\ 0\\.03433375394685918\ \(0\)\
\-\ with\\:\\ 0\\.034059692784873793\ \(0\)\
\-\ pain\\:\\ 0\\.031121127110956846\ \(0\)\
\-\ left\\:\\ 0\\.029667421490706607\ \(0\)\
\-\ on\\:\\ 0\\.026266483879248136\ \(0\)\
